Teresa López‐Fernández
Hospital Universitario La Paz(ES)Hospital La Paz Institute for Health Research(ES)
Publications by Year
Research Areas
Chemotherapy-induced cardiotoxicity and mitigation, Cardiac Imaging and Diagnostics, Cardiac Valve Diseases and Treatments, Cardiovascular Function and Risk Factors, Heart Failure Treatment and Management
Most-Cited Works
- → 2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)(2022)2,508 cited
- → 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines(2016)2,487 cited
- → Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society(2020)734 cited
- → Defining cardiovascular toxicities of cancer therapies: an International Cardio-Oncology Society (IC-OS) consensus statement(2021)555 cited
- → Role of Cardiovascular Imaging in Cancer Patients Receiving Cardiotoxic Therapies: A Position Statement on Behalf of the Heart Failure Association (HFA), the European Association of Cardiovascular Imaging (EACVI) and the Cardio-Oncology Council of the European Society of Cardiology (ESC)(2020)351 cited